Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2022-0469 | Other Grant/Funding Number | Fondazione Cariplo |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to investigate whether genetic variation in the TNFAIP3 locus is associated with immune-mediated thrombotic thrombocytopenic purpura (iTTP), and whether such association is mediated by decreased expression of A20 (TNFAIP3). The study includes a case-control design to assess genotype-expression association and a cohort study to evaluate clinical outcomes such as disease relapse.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with iTTP | Other | Intervention: blood sampling during standard collection for routine testing, with additional sample for experimental analyses. |
|
| Healthy donors | Other | Intervention: blood sampling during standard donation, with an additional sample collected for experimental analyses. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| blood sampling | Procedure | Blood sampling for experimental analyses. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Allele frequency of TNFAIP3 variants in cases vs controls | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| TNFAIP3 (A20) mRNA expression levels in peripheral blood | TNFAIP3 (A20) mRNA expression levels in peripheral blood of cases versus controls | Baseline |
| Association between TNFAIP3 genotype and gene expression |
Not provided
Patients:
Inclusion Criteria:
Exclusion Criteria:
Controls will be healthy Italian volunteers of Caucasian ethnicity, with no history of thrombotic thrombocytopenic purpura, frequency-matched to cases by age and sex, and who have provided written informed consent to participate in the study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ilaria Mancini, PhD | Contact | +390255035414 | ilaria.mancini@guest.unimi.it |
| Name | Affiliation | Role |
|---|---|---|
| Ilaria Mancini, PhD | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Recruiting | Milan | 20122 | Italy |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| C536901 | Thrombotic thrombocytopenic purpura, acquired |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001800 | Blood Specimen Collection |
| ID | Term |
|---|---|
| D013048 | Specimen Handling |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Baseline |
| Clinical relapse rate of iTTP during follow-up | Association between TNFAIP3/A20 variation and iTTP relapse in iTTP patients | Baseline |
| Severity of acute iTTP episodes | Association between TNFAIP3/A20 variation and the severity of acute iTTP (composite endpoint including death, treatment refractoriness, exacerbation, and prolonged disease course) | Baseline |
| Age at iTTP onset | Association between TNFAIP3/A20 variation and age at onset in iTTP patients | Baseline |
| D011677 | Punctures |
| D013514 | Surgical Procedures, Operative |
| D008919 | Investigative Techniques |